Sales, Marcelina D.

HRN: 16-75-28  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2026
MUPIROCIN 2%, 15G (TUBE)
05/21/2026
05/27/2026
TOPICAL
Apply Thin Layer
Now
IJC Exit Site Prophylaxis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines